 |
 |

Regression of In-Transit Melanoma of the Scalp With Intralesional Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine with multiple functions. It is produced by T cells, B cells, macrophages, mast cells, endothelial cells, and fibroblasts. Dranoff et al1 were the first to show the antitumor reactivity in B16 mice following active immunization with B16 melanoma cells transfected with the GM-CSF gene. Granulocyte-macrophage colony-stimulating factor has also been reported to accelerate pressure ulcer healing, and regression of metastatic carcinoma in skin appendages.2-3 Recently, Leong et al4 demonstrated that autologous tumor vaccine with local recombinant human GM-CSF (rhGM-CSF) injections resulted in tumor regression in patients with stage IV melanoma.
Report of a Case
An 83-year-old white woman presented with a medical history of squamous cell carcinoma, solar keratosis, and melanoma in situ of the right upper eyelid. When the patient was first seen at the University of California, San Francisco, Melanoma Center on July 28, 1997, a 2-cm brown to black, irregular-bordered plaque of the . . . [Full Text of this Article] Comment
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Complete Remission of Brain Metastases in Three Patients with Stage IV Melanoma Treated with BOLD and G-CSF
Bottoni et al.
Jpn J Clin Oncol 2005;35:507-513.
ABSTRACT
| FULL TEXT
Phase I Study of the Intratumoral Administration of Recombinant Canarypox Viruses Expressing B7.1 and Interleukin 12 in Patients with Metastatic Melanoma
Triozzi et al.
Clin. Cancer Res. 2005;11:4168-4175.
ABSTRACT
| FULL TEXT
Quantitative Analysis of Melanoma-Induced Cytokine-Mediated Immunosuppression in Melanoma Sentinel Nodes
Lee et al.
Clin. Cancer Res. 2005;11:107-112.
ABSTRACT
| FULL TEXT
Granulocyte-Macrophage Colony-Stimulating Factor: Another Cytokine With Adjuvant Therapeutic Benefit in Melanoma?
Lawson and Kirkwood
JCO 2000;18:1603-1605.
FULL TEXT
|